Next Article in Journal
Brugada Syndrome
Previous Article in Journal
Ion Channels and Beating Heart: The Players and the Music
 
 
Cardiogenetics is published by MDPI from Volume 10 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Long QT Syndrome: From Genetic Basis to Treatment

by
Lia Crotti
1,2,3,*,
Federica Dagradi
1,2 and
Peter J. Schwartz
1,2,4,5
1
Department of Molecular Medicine, Blood and Heart, Section of Cardiology, University of Pavia, Pavia, Italy
2
Department of Cardiology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
3
Institute of Human Genetics, Helmholtz Center Munich, Neuherberg, Germany
4
Chair of Sudden Death, Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
5
Cardiovascular Genetics Laboratory, Hatter Institute for Cardiovascular Research, Department of Medicine, University of Cape Town, Cape Town, South Africa
*
Author to whom correspondence should be addressed.
Cardiogenetics 2011, 1(s1), e2; https://doi.org/10.4081/cardiogenetics.2011.s1.e2
Submission received: 10 October 2011 / Revised: 10 October 2011 / Accepted: 9 November 2011 / Published: 20 November 2011

Abstract

The congenital long QT syndrome (LQTS) is a monogenic disorder, not as rare as it was originally estimated to be, mainly caused by mutations in genes encoding for ion channels. Molecular screening in this disease is part of the diagnostic process and this has already been recognized by current guidelines since 2006. However, very recently, two consensus documents have been published, with the recommendations for the use of genetic testing in the clinical evaluation of genetically transmitted arrhythmogenic diseases. Therefore, we devoted a specific section of the present review to the discussion of these two documents in relation to LQTS. The clinical presentation of the disease is typically characterized by a prolongation of the QT interval on the electrocardiogram (ECG) and by the occurrence of syncope or cardiac arrest, mainly precipitated by sympathetic activation. While the diagnosis of typical cases it is quite easy, borderline cases can be quite challenging and therefore the availability of diagnostic criteria is very useful to support the diagnostic process. Very recently, the LQTS diagnostic criteria have been updated and they are presented in the current review. Finally, the clinical management of LQTS patients is presented together with a schematic flow-chart and recent data coming from the LQTS-ICD European registry are illustrated. The last part of the review is dedicated at future perspectives and latest results on modifier genes and stem cells are presented.
Keywords: long QT syndrome; sudden cardiac death; genetics; ICD long QT syndrome; sudden cardiac death; genetics; ICD

Share and Cite

MDPI and ACS Style

Crotti, L.; Dagradi, F.; Schwartz, P.J. Long QT Syndrome: From Genetic Basis to Treatment. Cardiogenetics 2011, 1, e2. https://doi.org/10.4081/cardiogenetics.2011.s1.e2

AMA Style

Crotti L, Dagradi F, Schwartz PJ. Long QT Syndrome: From Genetic Basis to Treatment. Cardiogenetics. 2011; 1(s1):e2. https://doi.org/10.4081/cardiogenetics.2011.s1.e2

Chicago/Turabian Style

Crotti, Lia, Federica Dagradi, and Peter J. Schwartz. 2011. "Long QT Syndrome: From Genetic Basis to Treatment" Cardiogenetics 1, no. s1: e2. https://doi.org/10.4081/cardiogenetics.2011.s1.e2

APA Style

Crotti, L., Dagradi, F., & Schwartz, P. J. (2011). Long QT Syndrome: From Genetic Basis to Treatment. Cardiogenetics, 1(s1), e2. https://doi.org/10.4081/cardiogenetics.2011.s1.e2

Article Metrics

Back to TopTop